{
  "id": "22791e5dc06024c3",
  "title": "Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE - 006 for Alpha - 1 Antitrypsin Deficiency",
  "description": "20260202T131500Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/02/02/tmt-newswire/globenewswire/wave-life-sciences-announces-plans-to-accelerate-regulatory-engagement-with-full-control-of-wve-006-for-alpha-1-antitrypsin-deficiency/2269698",
  "published_at": "20260202T131500Z",
  "fetched_at": "2026-02-03T00:29:56.519436+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "regulatory"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/02/02/tmt-newswire/globenewswire/wave-life-sciences-announces-plans-to-accelerate-regulatory-engagement-with-full-control-of-wve-006-for-alpha-1-antitrypsin-deficiency/2269698",
    "url_mobile": "https://www.manilatimes.net/2026/02/02/tmt-newswire/globenewswire/wave-life-sciences-announces-plans-to-accelerate-regulatory-engagement-with-full-control-of-wve-006-for-alpha-1-antitrypsin-deficiency/2269698/amp",
    "title": "Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE - 006 for Alpha - 1 Antitrypsin Deficiency",
    "seendate": "20260202T131500Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/02/02/921523.jpg",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}